Samsung Launches its Medical Equipment Brand 'GEO' at ECR 2013

on Mar 07, 2013

Samsung expands its medical equipment business in the European market

VIENNA, Austria – March 7, 2013 – – Samsung Electronics Co., Ltd. today announced that it will launch its medical brand “GEO with Samsung Medison at the European Congress of Radiology (ECR)* 2013, which is held in Vienna from March 7 to March 11. Samsung will also be showcasing its latest medical equipment and technologies with Samsung Medison.

Samsung’s new medical device brand, GEO, is Greek for earth, and is included in model names to demonstrate the company’s commitment to global health through innovative medical devices. The GEO brand includes XGEO for digital radiography, UGEO for ultrasound diagnostic system and LABGEO for in-vitro diagnostics.

“Samsung is committed to bringing a new wave of innovation to the radiology market in Europe with our newly established medical equipment brand,” said S. I. Cho, president and head of the Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “Samsung will continue to develop products that offer fast, accurate diagnosis to both doctors and patients.


Introducing the New Brand and New Modality

In the XGEO exhibit, GC80, which targets large- and medium-sized hospitals, will introduce Samsung Electronics’ high-quality DR performance through panel detectors. Even with dose reduction, XGEO GC80 still guarantees accurate images and diagnosis which are critical for the health and safety of patients. Attendees will also have a chance to look into soft handling technology that allows users to move the device with low physical pressure even without a side-handle.

The UGEO exhibit highlights ultrasound systems that are equipped with increased functionality and performance. The upgraded Accuvix A30, which features the **Single Crystal Transducer optimized for radiology, will also be introduced. Additionally, Samsung Electronics will display portable CT products from NeuroLogica for the first time. The company was acquired by Samsung Electronics earlier in 2013.


Presenting Academic Efforts

At Blue Level (U2) Room G/H, Samsung will host ‘Satellite Symposium’ on the 10th (Sunday), from 12:30 to 1:30 pm, under the subject of “A New Tool for Detecting and Diagnosing Breast Cancer: Ultrasound ElastoScan™.” Speakers will discuss the technology within ElastoScan™ and its diagnostic capability to help detect breast cancer at an early stage and support surgery procedure.

Time | Topic | Speaker | Speaker's Info
12:30 ~ 12:45 Introduction to ElastoScan™   Wim van de Vooren Clinical Marketing Manager,
Samsung Electronics
European Headquarters
12:45 ~ 13:05 The Positive Influence of ElastoScan™
on Early Breast
Cancer Detection
  Dr. Volker Duda Sonologist, Marburg University,
13:05 ~ 13:25 Has ElastoScan™ posivively influenced
the way of breast surgery?
  Dr. Christine Kohler Breast Surgeon,
Marburg University, Germany
13:25 ~ 13:30 Q & A   All -

Reservations will take place at Entrance Level EXPO A, 13 (lunch provided).


Note to Editors:

*The European Congress of Radiology (ECR)) is the annual meeting of the European Society of Radiology (ESR) with more than 20,000 participants from around 100 countries. It represents the medical specialty of radiology throughout Europe and the Mediterranean. The ECR comprises a Congress Committee, a Programme Planning Committee, and 17 Scientific Subcommittees.

**The Single Crystal probe (transducer) provides a wide bandwidth which allows the user to utilize a wider range of frequencies, granting a better resolution and penetration.


About Samsung Electronics Co., Ltd.

Samsung Electronics Co., Ltd. is a global leader in technology, opening new possibilities for people everywhere. Through relentless innovation and discovery, we are transforming the worlds of televisions, smartphones, personal computers, printers, cameras, home appliances, LTE systems, medical devices, semiconductors and LED solutions. We employ 236,000 people across 79 countries with annual sales exceeding KRW 201 trillion. To discover more, please visit


About Samsung Medison

Samsung Medison is a leading global medical devices company. Founded in 1985, the company now sells cutting-edge medical devices including diagnostic ultrasound, digital X-ray and blood analyzer, in 110 countries around the world. The company has attracted global attention in the medical field with its R&D capabilities and advanced technologies. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world's best IT, image processing, semiconductor and communication technologies into medical devices. For more information, please visit

Next / Previous News Artilces
Previous Samsung Partnership with Scotland’s NHS Highlights Lifesaving Potential of Mobile Cardiac Diagnosis
Next Samsung Electronics America Acquires Medical Imaging Company – NeuroLogica